Could a headset boost brainpower in teens with a rare genetic condition?
NCT ID NCT05664412
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a gentle brain stimulation technique called tACS, used at home for 5 days a week over 4 weeks, can improve memory and thinking in 40 young people aged 14-25 with 22q11.2 deletion syndrome. The stimulation is personalized based on each participant's MRI and EEG results. The main goal is to check safety and tolerability, with a secondary focus on whether it helps working memory.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial alternating current stimulation (tACS) via a home device
What this could lead to
If it works, this could offer a safe, at-home way to boost memory and thinking skills in young people with 22q11.2 deletion syndrome, potentially delaying or preventing later psychotic symptoms.
What could go wrong
This is a small, early-stage trial (40 people) focused mainly on safety. The cognitive benefits are unproven, and the stimulation may cause mild side effects like headache or tingling. Results may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TACS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Geneva
RECRUITINGGeneva, Canton of Geneva, 1200, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••